|
US5965132A
(en)
*
|
1992-03-05 |
1999-10-12 |
Board Of Regents, The University Of Texas System |
Methods and compositions for targeting the vasculature of solid tumors
|
|
US6749853B1
(en)
|
1992-03-05 |
2004-06-15 |
Board Of Regents, The University Of Texas System |
Combined methods and compositions for coagulation and tumor treatment
|
|
DE19845798A1
(de)
*
|
1998-09-29 |
2000-04-13 |
Schering Ag |
Verwendung von Neoangiogenese-Markern für Diagnose und Therapie von Tumoren, diese enthaltende Mittel, sowie Verfahren zu deren Herstellung
|
|
JP4531267B2
(ja)
*
|
1999-01-22 |
2010-08-25 |
ザ バーナム インスティチュート |
ホーミングプロアポトーシス結合体およびホーミングプロアポトーシス結合体を使用する方法
|
|
WO2001058240A2
(en)
*
|
2000-02-10 |
2001-08-16 |
Massachusetts Eye And Ear Infirmary |
Photodynamic therapy for treating conditions of the eye
|
|
AU2006203034B2
(en)
*
|
2000-02-10 |
2006-09-07 |
Massachusetts Eye And Ear Infirmary |
Methods and compositions for treating conditions of the eye
|
|
DE10043481A1
(de)
*
|
2000-09-04 |
2002-04-11 |
Vectron Therapeutics Ag Imt |
Humaner Antikörper gegen Endoglin (CD105) und seine Verwendung
|
|
JP2003021631A
(ja)
*
|
2001-05-10 |
2003-01-24 |
Chugai Pharmaceut Co Ltd |
骨転移抑制剤のスクリーニング方法
|
|
WO2003028840A2
(en)
*
|
2001-09-27 |
2003-04-10 |
Board Of Regents, The University Of Texas System |
Combined compositions and methods for tumor vasculature coagulation and treatment
|
|
US20050106667A1
(en)
|
2003-08-01 |
2005-05-19 |
Genentech, Inc |
Binding polypeptides with restricted diversity sequences
|
|
US7758859B2
(en)
|
2003-08-01 |
2010-07-20 |
Genentech, Inc. |
Anti-VEGF antibodies
|
|
WO2005044853A2
(en)
*
|
2003-11-01 |
2005-05-19 |
Genentech, Inc. |
Anti-vegf antibodies
|
|
AP2740A
(en)
*
|
2003-08-01 |
2013-09-30 |
Genentech Inc |
Anti-VEGF antibodies
|
|
EP1533617A1
(en)
*
|
2003-11-19 |
2005-05-25 |
RMF Dictagene S.A. |
Angiogenesis inhibiting molecules, their selection, production and their use in the treatment and diagnosis of cancer
|
|
WO2006020979A2
(en)
*
|
2004-08-13 |
2006-02-23 |
Yale University |
Factor vii conjugates for selectively treating neovascularization disorders
|
|
EP2347765B1
(en)
|
2004-09-24 |
2014-01-22 |
Beth Israel Deaconess Medical Center |
Methods of diagnosing and treating complications of pregnancy
|
|
US7740849B2
(en)
*
|
2004-09-24 |
2010-06-22 |
Beth Israel Deaconess Medical Center |
Use of compounds that bind soluble endoglin and SFLT-1 for the treatment of pregnancy related hypertensive disorders
|
|
DE602005023216D1
(de)
*
|
2004-12-15 |
2010-10-07 |
Beth Israel Hospital |
Nukleinsäuren und polypeptide zur diagnose und behandlung von schwangerschaftskomplikationen
|
|
US20090286271A1
(en)
*
|
2006-05-31 |
2009-11-19 |
Karumanchi Ananth S |
Methods of Diagnosing and Treating Complications of Pregnancy
|
|
CN111518218A
(zh)
|
2006-11-02 |
2020-08-11 |
阿塞勒隆制药公司 |
Alk1受体和配体拮抗剂及其用途
|
|
US8642031B2
(en)
|
2006-11-02 |
2014-02-04 |
Acceleron Pharma, Inc. |
Antagonists of BMP9, BMP10, ALK1 and other ALK1 ligands, and uses thereof
|
|
US10059756B2
(en)
|
2006-11-02 |
2018-08-28 |
Acceleron Pharma Inc. |
Compositions comprising ALK1-ECD protein
|
|
TWI468417B
(zh)
|
2007-11-30 |
2015-01-11 |
Genentech Inc |
抗－ｖｅｇｆ抗體
|
|
JP5719766B2
(ja)
|
2008-05-02 |
2015-05-20 |
アクセルロン ファーマ， インコーポレイテッド |
血管新生および周皮細胞組成物を調節するための方法および組成物
|
|
US20100082438A1
(en)
*
|
2008-10-01 |
2010-04-01 |
Ronnie Jack Garmon |
Methods and systems for customer performance scoring
|
|
US20120244147A1
(en)
*
|
2009-08-17 |
2012-09-27 |
Theuer Charles P |
Combination therapy of cancer with anti-endoglin antibodies and anti-vegf agents
|
|
US8221753B2
(en)
*
|
2009-09-30 |
2012-07-17 |
Tracon Pharmaceuticals, Inc. |
Endoglin antibodies
|
|
AU2010329904B2
(en)
*
|
2009-12-09 |
2015-07-09 |
Bayer Pharma Aktiengesellschaft |
Anti-C4.4a antibodies and uses thereof
|
|
US9315582B2
(en)
|
2011-02-23 |
2016-04-19 |
Health Research, Inc. |
Anti-endoglin antibodies and knockin mice expressing novel human/mouse chimeric endoglin
|
|
US9255595B2
(en)
*
|
2011-04-29 |
2016-02-09 |
Bae Systems Information And Electronic Systems Integration Inc. |
Optical dome bezel
|
|
UA115789C2
(uk)
|
2012-09-05 |
2017-12-26 |
Трейкон Фармасутікалз, Інк. |
Композиція антитіла до cd105 та її застосування
|
|
EP3008667B1
(en)
|
2013-06-14 |
2019-01-16 |
Agilent Technologies, Inc. |
System and method for facilitating manual sorting of objects
|
|
GB201402006D0
(en)
|
2014-02-06 |
2014-03-26 |
Oncomatryx Biopharma S L |
Antibody-drug conjugates and immunotoxins
|
|
CA2966905A1
(en)
|
2014-11-12 |
2016-05-19 |
Tracon Pharmaceuticals, Inc. |
Anti-endoglin antibodies and uses thereof
|
|
US9926375B2
(en)
|
2014-11-12 |
2018-03-27 |
Tracon Pharmaceuticals, Inc. |
Anti-endoglin antibodies and uses thereof
|
|
PE20181363A1
(es)
|
2015-09-23 |
2018-08-27 |
Genentech Inc |
Variantes optimizadas de anticuerpos anti-vegf
|
|
RU2607029C1
(ru)
*
|
2015-10-20 |
2017-01-10 |
ФЕДЕРАЛЬНОЕ ГОСУДАРСТВЕННОЕ БЮДЖЕТНОЕ УЧРЕЖДЕНИЕ "РОССИЙСКИЙ НАУЧНЫЙ ЦЕНТР РАДИОЛОГИИ И ХИРУРГИЧЕСКИХ ТЕХНОЛОГИЙ" МИНИСТЕРСТВА ЗДРАВООХРАНЕНИЯ РОССИЙСКОЙ ФЕДЕРАЦИИ / ФГБУ "РНЦРХТ" Минздрава России |
ШТАММ ГИБРИДНЫХ КУЛЬТИВИРУЕМЫХ КЛЕТОК ЖИВОТНЫХ Mus musculus L. - EN-4C9 - ПРОДУЦЕНТ МОНОКЛОНАЛЬНЫХ АНТИТЕЛ ПРОТИВ ЭНДОГЛИНА (CD105) ЧЕЛОВЕКА
|
|
CN106928359B
(zh)
*
|
2015-12-30 |
2020-10-13 |
广西医科大学 |
一种CD105纳米抗体Nb59
|
|
CN106928355B
(zh)
*
|
2015-12-30 |
2020-09-29 |
广西医科大学 |
一种CD105纳米抗体Nb184
|
|
GB2594002B
(en)
|
2016-06-24 |
2022-04-13 |
Univ South Carolina |
Inhibin as targetable regulators of angiogenesis
|
|
EP3900733A1
(en)
|
2020-04-24 |
2021-10-27 |
Derma Innovate S.L. |
Src kinase activators and eng function inhibitors as enhancers of skin homeostasis/regeneration and hair growth
|
|
CN115991773B
(zh)
*
|
2022-08-15 |
2023-11-17 |
营龄(武汉)生物科技有限公司 |
一种含有人血白蛋白的药物组合物
|
|
CN116063496B
(zh)
*
|
2022-08-15 |
2023-10-24 |
营龄(武汉)生物科技有限公司 |
载药的人血白蛋白联合单克隆抗体在制备药物组合物中的用途
|
|
WO2026017807A1
(en)
|
2024-07-18 |
2026-01-22 |
Beech Biotech Sa |
Compositions and uses thereof
|